Susquehanna International Group, LLP Omeros Corp Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Omeros Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 30,268 shares of OMER stock, worth $204,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,268

Previous 54,555 44.52%

Holding current value

$204,309

Previous $221,000 45.7%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.54 - $5.47 $85,975 - $132,849	-24,287 Reduced 44.52%	30,268 $120,000
Q2 2024 Aug 15, 2024	BUY	$3.04 - $4.23 $2,666 - $3,709	877 Added 1.63%	54,555 $221,000
Q1 2024 May 07, 2024	SELL	$2.88 - $4.89 $172,874 - $293,527	-60,026 Reduced 52.79%	53,678 $185,000
Q4 2023 Feb 14, 2024	SELL	$1.08 - $3.63 $66,984 - $225,143	-62,023 Reduced 35.3%	113,704 $371,000
Q3 2023 Nov 14, 2023	BUY	$2.81 - $5.69 $95,399 - $193,175	33,950 Added 23.95%	175,727 $513,000
Q2 2023 Aug 11, 2023	SELL	$4.45 - $7.57 $948,303 - $1.61 Million	-213,102 Reduced 60.05%	141,777 $771,000
Q1 2023 May 16, 2023	BUY	$2.48 - $5.22 $77,420 - $162,957	31,218 Added 9.65%	354,879 $1.65 Million
Q4 2022 Feb 14, 2023	BUY	$1.75 - $3.96 $271,264 - $613,831	155,008 Added 91.91%	323,661 $731,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $7.46 $45,444 - $109,714	14,707 Added 9.55%	168,653 $531,000
Q2 2022 Aug 15, 2022	SELL	$1.92 - $6.28 $14,161 - $46,321	-7,376 Reduced 4.57%	153,946 $423,000
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $624,269 - $886,536	-123,130 Reduced 43.29%	161,322 $970,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $250,120 - $376,725	44,113 Added 18.35%	284,452 $1.83 Million
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $469,897 - $571,592	35,067 Added 17.08%	240,339 $3.31 Million
Q2 2021 Aug 11, 2021	BUY	$14.81 - $19.13 $519,594 - $671,156	35,084 Added 20.61%	205,272 $3.05 Million
Q1 2021 May 17, 2021	SELL	$14.52 - $23.53 $1.92 Million - $3.12 Million	-132,462 Reduced 43.77%	170,188 $3.03 Million
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $355,701 - $532,850	-35,079 Reduced 10.39%	302,650 $4.32 Million
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $2 Million - $4.46 Million	209,366 Added 163.1%	337,729 $3.41 Million
Q2 2020 Aug 14, 2020	BUY	$12.21 - $16.99 $360,402 - $501,493	29,517 Added 29.86%	128,363 $1.89 Million
Q1 2020 May 15, 2020	SELL	$9.03 - $19.72 $686,289 - $1.5 Million	-76,001 Reduced 43.47%	98,846 $1.32 Million
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.56 $944,120 - $1.33 Million	64,888 Added 59.01%	174,847 $2.86 Million
Q2 2019 Aug 16, 2019	BUY	$15.0 - $19.62 $91,245 - $119,348	6,083 Added 5.86%	109,959 $1.73 Million
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.62 $39,735 - $51,973	-2,649 Reduced 2.49%	103,876 $1.63 Million
Q1 2019 May 15, 2019	SELL	$11.65 - $17.72 $414,239 - $630,070	-35,557 Reduced 25.03%	106,525 $1.85 Million
Q4 2018 Feb 14, 2019	SELL	$10.72 - $16.73 $5.83 Million - $9.1 Million	-543,794 Reduced 79.28%	142,082 $1.58 Million
Q3 2018 Nov 14, 2018	SELL	$17.73 - $26.69 $4.77 Million - $7.19 Million	-269,267 Reduced 28.19%	685,876 $16.7 Million
Q2 2018 Aug 14, 2018	BUY	$10.79 - $24.44 $1.71 Million - $3.86 Million	158,052 Added 19.83%	955,143 $17.3 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $5.61 Million - $12.6 Million	-622,953 Reduced 43.87%	797,091 $8.9 Million
Q4 2017 Feb 14, 2018	BUY	$13.26 - $22.86 $9.47 Million - $16.3 Million	714,232 Added 101.19%	1,420,044 $27.6 Million
Q3 2017 Nov 14, 2017	BUY	$19.76 - $24.9 $13.9 Million - $17.6 Million	705,812	705,812 $15.3 Million

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $423M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Omeros Corp Transaction History